Miromatrix Medical Inc (MIRO) Financials

$3.39

$0.00 (0.00%)

As on 22-Dec-2023 09:30EDT

Market cap

$93 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

--

P/B Ratio

6

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	0.96	0.95	0.03	0.05	0.25	--
Cost of Revenue	0.50	0.50	0.50	0.50	0.25	--
Gross Profit	0.46	0.45	-0.47	-0.45	--	--
Operating Expenses	28.94	30.70	16.10	8.81	8.56	--
Operating Profit (EBIT)	-28.48	-30.25	-16.96	-10.26	-8.99	--
Other Income	0.16	--	--	--	--	--
Profit before Tax	-27.41	-29.96	-14.67	-10.31	-9.53	--
Provision for Tax	0.07	0.05	0.28	-1.59	-6.46	--
Profit after Tax (Net Income)	-27.12	-30.01	-14.96	-8.72	-3.07	--
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-6.53	--	-14.67	-10.31	-4.05	--

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	15.54	26.11	54.13	-51.03	-41.43	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	2.91	3.71	2.24	48.12	47.56	--
Current Liabilities	4.97	4.95	4.56	8.16	1.62	--
Total Liabilities	28.39	34.76	60.93	5.25	7.75	--

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	6.23	7.45	5.59	0.56	3.87	--
Current Assets	17.19	27.31	55.34	4.69	3.87	--
Total Assets	28.39	34.76	60.93	5.25	7.75	--
Total Debt*	3.22	3.55	0.83	7.34	1.14	--
Net Current Assets	12.23	22.36	50.77	-3.47	2.25	--

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-26.68	-14.81	-8.04	-8.32	--
Cash Flow from Investing Activities	--	--	-1.38	2.88	10.36	--
Cash from Financing Activities	--	0.17	65.36	6.36	0.31	--
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-1.12	-1.43	-1.36	--	--	--
Cash EPS ($)	--	-1.38	-1.34	--	--	--
Adjusted Book Value ($)	--	1.24	4.92	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.27	-1.35	--	--	--
Free Cash Flow per Share ($)	--	-1.32	-1.65	--	--	--

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	-70.93	-265.53	20.76	--	--
ROE (%)	-125.15	-74.80	-967.48	18.85	--	--
ROA (%)	-74.25	-62.72	-45.19	-134.10	--	--
EBIT Margin (%)	-2,935.30	-3,172.17	-51,289.94	-22,047.17	-3,596.67	--
Net Margin (%)	-2,430.11	-3,147.22	-45,229.95	-18,732.75	-1,228.07	--
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	2,978.99	27.84	-0.29	-0.81	--	--
EBIT Growth (%)	2.07	-78.34	-65.32	-14.09	--	--
Net Profit Growth (%)	4.64	-100.64	-71.58	-183.90	--	--
EPS Growth (%)	30.11	-0.05	--	--	--	--
Book Value Growth (%)	-63.08	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	-2.09	-3.45	--	--	--
Price / Book Value	5.98	2.41	0.95	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-3.06	-1.38	0.02	--	--	--
Close Price ($)	1.31	2.99	4.69	--	--	--
High Price ($)	4.50	5.29	16.52	--	--	--
Low Price ($)	0.91	2.02	4.06	--	--	--
Market Cap ($ Cr)	92.95	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	0.02	0.14	0.02	-0.14	-0.03	--
Short term debt to equity ratio	0.03	0.02	0.01	-0.13	-0.01	--
Current Ratio	3.46	5.52	12.12	0.57	2.39	--
Quick Ratio	3.30	5.36	11.95	--	--	--
Interest Coverage	-589.56	-633.66	-25.07	-13.41	-185.84	--

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	9.46	108.89	3,855.23	247.59	211.12	--
Asset Turnover	0.03	0.02	0.00	0.01	--	--
Receivable days	--	443.02	7,676.87	2,523.73	771.12	--
Inventory Days	--	584.47	584.47	--	--	--
Payable days	--	1,344.04	812.69	158.21	442.66	--
Cash Conversion Cycle	--	-316.54	7,448.66	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.